Ranbaxy shares slump on $500 million fine to settle US drug safety charges
MUMBAI (Reuters) - Ranbaxy Laboratories Ltd shares fell 3.4 percent in pre-open trading on Tuesday after the Indian generic drugmake...
Read More »MUMBAI (Reuters) - Ranbaxy Laboratories Ltd shares fell 3.4 percent in pre-open trading on Tuesday after the Indian generic drugmake...
Read More »
By Toni Clarke (Reuters) - A House of Representatives panel is investigating the circumstances surrounding the resignation from the ...
Read More »
By David Morgan WASHINGTON (Reuters) - An Obama administration effort to raise private donations to help implement President Barack ...
Read More »(Reuters) - Medical device maker C.R. Bard Inc will pay about $48.3 million to resolve allegations it made illegal payments to hospi...
Read More »(Reuters) - The U.S. government on Monday issued a proposed rule for cutting payments to hospitals that treat a disproportionate sha...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite public health progress in cutting calories, as well as salt and fat from fas...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Primary care doctors should ask adults how much and how often they drink alcohol and ...
Read More »(Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and ...
Read More »By Estelle Shirbon LONDON (Reuters) - Two Paralyzed British men who want to die but cannot kill themselves went to court on Monday ...
Read More »
By Catherine Hornby ROME (Reuters) - The thought of eating beetles, caterpillars and ants may give you the creeps, but the authors o...
Read More »